$VERI
Veritone, Inc.

2020 Q1 Form 10-Q Financial Statement

#000156459020024366 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019 Q1
Revenue $11.90M $12.45M $12.13M
YoY Change -1.82% 13.7% 176.32%
Cost Of Revenue $3.811M $4.100M $3.870M
YoY Change -1.52% 16.15% 586.17%
Gross Profit $8.093M $8.350M $8.250M
YoY Change -1.9% 12.53% 115.74%
Gross Profit Margin 67.99% 67.07% 68.04%
Selling, General & Admin $16.47M $17.67M $17.82M
YoY Change -7.58% -3.23% 42.29%
% of Gross Profit 203.53% 211.62% 216.04%
Research & Development $3.646M $4.530M $6.938M
YoY Change -47.45% -37.08% 53.22%
% of Gross Profit 45.05% 54.25% 84.1%
Depreciation & Amortization $1.604M $1.610M $1.133M
YoY Change 41.57% -30.6% 219.15%
% of Gross Profit 19.82% 19.28% 13.73%
Operating Expenses $20.91M $22.98M $24.76M
YoY Change -15.57% -9.74% 45.19%
Operating Profit -$12.81M -$14.63M -$16.51M
YoY Change -22.39% -18.9% 24.78%
Interest Expense $80.00K $10.00K $160.0K
YoY Change -50.0% -96.67% -11.11%
% of Operating Profit
Other Income/Expense, Net $131.0K $90.00K $211.0K
YoY Change -37.91% -325.0% 15.3%
Pretax Income -$12.68M -$14.54M -$16.30M
YoY Change -22.19% -18.22% 24.91%
Income Tax $3.000K $350.0K $9.000K
% Of Pretax Income
Net Earnings -$12.68M -$14.88M -$16.31M
YoY Change -22.21% -16.36% 24.96%
Net Earnings / Revenue -106.55% -119.52% -134.48%
Basic Earnings Per Share
Diluted Earnings Per Share -$473.7K -$606.4K -$836.0K
COMMON SHARES
Basic Shares Outstanding 26.79M 19.58M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q4 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.20M $44.10M $50.90M
YoY Change -3.34% -13.7% -6.61%
Cash & Equivalents $50.02M $44.07M $41.00M
Short-Term Investments $0.00 $11.10M
Other Short-Term Assets $4.500M $5.400M $2.900M
YoY Change 55.17% 50.0% 26.09%
Inventory
Prepaid Expenses
Receivables $21.90M $21.35M $26.40M
Other Receivables $4.800M $10.20M $7.000M
Total Short-Term Assets $80.40M $81.11M $87.30M
YoY Change -7.9% -6.25% 21.98%
LONG-TERM ASSETS
Property, Plant & Equipment $3.000M $3.214M $3.814M
YoY Change -21.34% -19.81% 64.11%
Goodwill $6.904M $5.543M
YoY Change 25.32%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.200M $315.0K $49.00K
YoY Change 2348.98% -74.54% -94.67%
Total Long-Term Assets $25.80M $27.41M $30.20M
YoY Change -14.57% -12.23% 390.18%
TOTAL ASSETS
Total Short-Term Assets $80.40M $81.11M $87.30M
Total Long-Term Assets $25.80M $27.41M $30.20M
Total Assets $106.2M $108.5M $117.5M
YoY Change -9.62% -7.84% 51.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.20M $17.01M $20.70M
YoY Change -21.74% -40.75% 78.68%
Accrued Expenses $26.20M $23.50M $21.80M
YoY Change 20.18% 216.88% 215.39%
Deferred Revenue $9.080M
YoY Change -5.8%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $62.60M $59.74M $58.73M
YoY Change 6.59% 6.51% 120.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.300M $1.379M $1.276M
YoY Change 1.88% -0.51%
Total Long-Term Liabilities $1.300M $1.379M $1.276M
YoY Change 1.88% -0.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $62.60M $59.74M $58.73M
Total Long-Term Liabilities $1.300M $1.379M $1.276M
Total Liabilities $63.90M $61.12M $60.00M
YoY Change 6.49% 6.34% 125.58%
SHAREHOLDERS EQUITY
Retained Earnings -$232.5M -$186.7M
YoY Change 36.43% 52.45%
Common Stock $26.00K $20.00K
YoY Change 36.84% 25.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $42.27M $47.41M $57.50M
YoY Change
Total Liabilities & Shareholders Equity $106.2M $108.5M $117.5M
YoY Change -9.62% -7.84% 51.17%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019 Q1
OPERATING ACTIVITIES
Net Income -$12.68M -$14.88M -$16.31M
YoY Change -22.21% -16.36% 24.96%
Depreciation, Depletion And Amortization $1.604M $1.610M $1.133M
YoY Change 41.57% -30.6% 219.15%
Cash From Operating Activities $1.503M -$12.00M -$4.632M
YoY Change -132.45% -30.48% -65.04%
INVESTING ACTIVITIES
Capital Expenditures $9.000K -$10.00K $98.00K
YoY Change -90.82% -91.67% -94.21%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $2.470M
YoY Change -100.0% -100.0% -58.83%
Cash From Investing Activities -$9.000K -$10.00K $2.375M
YoY Change -100.38% -100.11% -43.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.505M $4.160M
YoY Change -15.75% -6600.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.606M 6.600M 4.484M
YoY Change -19.58% -11100.0% 811.38%
NET CHANGE
Cash From Operating Activities 1.503M -12.00M -4.632M
Cash From Investing Activities -9.000K -10.00K 2.375M
Cash From Financing Activities 3.606M 6.600M 4.484M
Net Change In Cash 5.100M -5.410M 2.227M
YoY Change 129.01% -37.02% -126.14%
FREE CASH FLOW
Cash From Operating Activities $1.503M -$12.00M -$4.632M
Capital Expenditures $9.000K -$10.00K $98.00K
Free Cash Flow $1.494M -$11.99M -$4.730M
YoY Change -131.59% -30.05% -68.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Liabilities
Liabilities
61115000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1379000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2486000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
29000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3902000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6938000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
3811000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
57499000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
26000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
279828000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-232489000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
46000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
47411000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
108526000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11543000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11690000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-42000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1503000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1604000
CY2019Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
13000
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4456000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5507000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
555000
CY2020Q1 veri Increase Decrease Expenditures Billable To Clients
IncreaseDecreaseExpendituresBillableToClients
-5446000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-406000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-763000
CY2020Q1 veri Increase Decrease Accrued Media Payments
IncreaseDecreaseAccruedMediaPayments
3334000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
947000
CY2020Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-644000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-12684000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25670737
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12812000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-16508000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
131000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
211000
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19511220
CY2020Q1 us-gaap Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements
IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements
21163
CY2019Q4 veri Cash And Cash Equivalents And Available For Sale Debt Securities Fair Value
CashAndCashEquivalentsAndAvailableForSaleDebtSecuritiesFairValue
44065000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25670737
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
20905000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
24761000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-16306000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26773163
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
35000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-21000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12680000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16292000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2984000
CY2020Q1 veri Stock Issued During Period Value Employee Stock Plans
StockIssuedDuringPeriodValueEmployeeStockPlans
101000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4456000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
60283000
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4160000
CY2019Q1 veri Stock Issued During Period Value Employee Stock Plans
StockIssuedDuringPeriodValueEmployeeStockPlans
324000
CY2019Q1 veri Adjustments To Additional Paid In Capital Acquisition Holdback Consideration
AdjustmentsToAdditionalPaidInCapitalAcquisitionHoldbackConsideration
458000
CY2019Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3764000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4803000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-12684000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-16306000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1133000
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2000
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
19000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2716000
CY2019Q1 veri Increase Decrease Expenditures Billable To Clients
IncreaseDecreaseExpendituresBillableToClients
4331000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-637000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7999000
CY2019Q1 veri Increase Decrease Accrued Media Payments
IncreaseDecreaseAccruedMediaPayments
5927000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
6582000
CY2019Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1593000
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-110000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4632000
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2473000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
98000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3505000
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
101000
CY2019Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
324000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3606000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4484000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5100000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2227000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44920000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38776000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50020000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41003000
CY2020Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain reclassifications to other assets have been made to prior year amounts for consistency and comparability with the current year&#8217;s financial statements presentation. These reclassifications had no effect on the reported total assets.</p>
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Accounting Estimates</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to revenue recognition, allowance for doubtful accounts, the valuation of stock awards and stock warrants and income taxes. Actual results could differ from those estimates.</p>
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-61104000
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5767000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30117000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41770000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-62078000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1909000
CY2019Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
745000
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.64
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26794326
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19579332
CY2019Q1 us-gaap Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements
IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements
68112
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11078959
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10597934
CY2020Q1 veri Cash And Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashAndCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
49165000
CY2020Q1 veri Cash And Cash Equivalents And Available For Sale Debt Securities Fair Value
CashAndCashEquivalentsAndAvailableForSaleDebtSecuritiesFairValue
49165000
CY2019Q4 veri Cash And Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashAndCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
44065000
CY2020Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P3Y2M12D
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23882000
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9104000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23882000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7756000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1348000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
841000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4034000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4261000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3963000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2520000
CY2020Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
21946000
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
21381000
CY2020Q1 veri Property And Equipment Gross
PropertyAndEquipmentGross
2256000
CY2019Q4 veri Property And Equipment Gross
PropertyAndEquipmentGross
2247000
CY2020Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2876000
CY2019Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2876000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5132000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5123000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2165000
CY2020Q1 us-gaap Depreciation
Depreciation
256000
CY2019Q1 us-gaap Depreciation
Depreciation
292000
CY2020Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
14848000
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
15697000
CY2020Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1385000
CY2019Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1299000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
77000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
169000
CY2020Q1 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
52000
CY2019Q1 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
55000
CY2020Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
766000

Files In Submission

Name View Source Status
0001564590-20-024366-index-headers.html Edgar Link pending
0001564590-20-024366-index.html Edgar Link pending
0001564590-20-024366.txt Edgar Link pending
0001564590-20-024366-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
veri-10q_20200331.htm Edgar Link pending
veri-20200331.xml Edgar Link completed
veri-20200331.xsd Edgar Link pending
veri-20200331_cal.xml Edgar Link unprocessable
veri-20200331_def.xml Edgar Link unprocessable
veri-20200331_lab.xml Edgar Link unprocessable
veri-20200331_pre.xml Edgar Link unprocessable
veri-ex311_6.htm Edgar Link pending
veri-ex312_8.htm Edgar Link pending
veri-ex321_7.htm Edgar Link pending